Literature DB >> 19584004

Biotech acquisitions by big pharma: why and what is next.

Nafees N Malik1.   

Abstract

Leading pharmaceutical companies are increasingly making biotech acquisitions to help them refill their pipelines, but what makes a good acquisition target and what will be the impact of the present financial crisis on deals.

Mesh:

Year:  2009        PMID: 19584004     DOI: 10.1016/j.drudis.2009.06.012

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  2 in total

1.  Medicines as a Service: A New Commercial Model for Big Pharma in the Postblockbuster World.

Authors:  Soeren Mattke; Lisa Klautzer; Tewodaj Mengistu
Journal:  Rand Health Q       Date:  2012-06-01

Review 2.  Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry.

Authors:  Chie Hoon Song; Jeung-Whan Han
Journal:  Springerplus       Date:  2016-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.